SIRT1 and prostate carcinoma: To corroborate their finding, the authors further demonstrated that siRNA-mediated knockdown of SIRT1 reduced MMP2 protein stability and zymographic activity and consequently inhibited the invasion of PC3 prostate cancer cells.